InfuSystem Holdings (INFU) Net Margin Growth (3y) (2013 - 2026)
InfuSystem Holdings (INFU) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -641.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 941.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -1,024.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 574.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 216.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 647.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 300.00 |
| 10 | InfuSystem Holdings | 243.66 Mn | 242.70 Mn | 21.41 Mn | 747.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 747.00 |
| Mar 31, 2026 | 401.00 |
| Dec 31, 2025 | 521.00 |
| Sep 30, 2025 | 457.00 |
| Jun 30, 2025 | 783.00 |
| Mar 31, 2025 | 60.00 |
| Dec 31, 2024 | 133.00 |
| Sep 30, 2024 | 674.00 |
| Jun 30, 2024 | -131.00 |
| Mar 31, 2024 | -622.00 |
| Dec 31, 2023 | -4,288.00 |
| Sep 30, 2023 | -945.00 |
| Jun 30, 2023 | -1,455.00 |
| Mar 31, 2023 | 95.00 |
| Dec 31, 2022 | -323.00 |
| Sep 30, 2022 | -366.00 |
| Jun 30, 2022 | -254.00 |
| Mar 31, 2022 | 404.00 |
| Dec 31, 2021 | 320.00 |
| Sep 30, 2021 | 143.00 |